ALACHUA, FL--(MARKET WIRE)--Jun 18, 2007 -- Oragenics, Inc. (AMEX:ONI - News), a biotechnology development company, announced today that Dr. Ronald Evens has been appointed to the Company’s Board of Directors. “Dr. Evens has a tremendous depth of pharmaceutical industry experience and we anticipate he will contribute significantly to the growth of Oragenics. We are very pleased to welcome Ron to our Board,” said David Gury, Chairman of Oragenics.
